期刊文献+

结直肠癌同时性肝转移的同期手术切除 被引量:1

Simultaneous liver and colorectal resection for synchronous colorectal liver metastasis
原文传递
导出
摘要 目的探讨同时性结直肠癌肝转移行同期切除原发瘤和肝转移瘤的安全性和有效性。方法回顾性总结分析从1981年5月至2005年11月在我院住院治疗的43例结直肠癌同时性肝转移同期手术的临床病理资料及结果并结合文献复习。结果 43例患者中男性21例,女性22例,中位年龄52岁,手术持续中位时间180 min。共30例术中输血,中位输血量800 ml。术后总住院时间10~50 d,中位时间15 d。并发症发生率18.6%(8/43),手术死亡率2.3%(1/43)。全组总的中位生存期为25个月,5年生存率19.1%。R0切除组的中位生存期48个月,5年生存率33.8%;非 R0切除组的中位生存期为20个月,5年生存率7.6%。两组的生存时间经 Log Rank 检验差异明显,P=0.002。结论同时性结直肠癌肝转移同期手术的安全性和有效性可以保证。对可切除的同时性结直肠癌肝转移应争取同期手术,并争取 R0切除。 Objective To investigate the safety and long term outcome of simultaneous liver and colorectal resection for synchronous colorectal liver metastasis. Methods Forty-three synchronous colorectal liver metastasis patients who received simultaneous colectomy and hepatectomy between May 1981 and November 2005 were analyzed retrospectively. Results The group included 21 male patients and 22 female patients, with the median age of 52 years. The overall median operative time was 180 minutes, 30 cases received blood transfusion, and the median volume was 800 ml. The median hospital stay was 15 days. The morbidity and mortality was 18. 6% and 2. 3%, respectively. The overall median survival time was 25 months,5-year survival rate was 19. 1%. The survival of patients underwent R0 resection were substantially better ( median survival time 48 months, 5-year survival rate 33. 8% ) than that of the patients who did not undergo R0 resection(20 months,7. 6% ) (P =0. 002). Conclusions Simultaneous liver and colorectal resection is safe and effective for synchronous colorectal liver metastasis. Furthermore, simultaneous R0 resection should be the optimal surgery for the resectable cases.
出处 《中华外科杂志》 CAS CSCD 北大核心 2007年第13期902-904,共3页 Chinese Journal of Surgery
关键词 结直肠肿瘤 肝肿瘤 继发性 肿瘤转移 Colorectal neoplasms Liver neoplasms,secondary Neoplasm metastasis
  • 相关文献

参考文献8

  • 1Minagawa M, Yamamoto J, Miwa S, et al. Selection criteria for simultaneous resection in patients with synchronous liver metastasis. Arch Surg, 2006, 141 : 1006-1012.
  • 2Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastaseis. J Am Coll Surg, 2003, 197:233-241.
  • 3Chua HK, Sondenaa K, Tsiotos GG, et al. Concurrent vs. Stage colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases. Dis Colon Rectum, 2004, 47: 1310-1316.
  • 4Santibanes ED, Lassalle FB, McCormack L, et al. Simultaneous colorectal and hepatic resections for colorectal cancer : postoperative and longterm outcomes. J Am Coil Surg, 2002, 195 : 196-202.
  • 5Weber JC, BacheUier P, Oussoultzoglou E, et al. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg, 2003, 90:956-962.
  • 6Nordlinger B, Guiguer M, Valliant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection ,based on 1568 patients. Cancer, 1996, 77 : 1254-1262.
  • 7Lambert LA, Colacchio TA, Barth R J, et al. Interval hepatic resection of colorectal metastases improves patient selection. Arch Surg, 2000, 135:473-480.
  • 8Charnsangavej C, Clary B, Fong Y, et al. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Onco, 2006, 13:1261-1268.

同被引文献8

  • 1Pawlik TM, Schlick RD, Choti MA. Expanding criteria for resect- ability of colorectal liver metastases [J]. Oncologist,2008,13(1): 51-64.
  • 2Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic coloreetal metastases [J]. Ann Surg, 2002, 235(6):759-766.
  • 3Simmonds PC, Primrose JN, Colquitt JL, et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies [J ]. Br J Cancer, 2006, 94 (7): 982-999.
  • 4Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorec- tal resections are safe for synchronous colorectal liver metastasis [J].J Am Coil Surg, 2003,197(2) : 233-241.
  • 5Are C, Gonen M, Zazzali K, et al. The impact of margins on out- come after hepatic resection for colorectal metastasis [J]. Ann Surg, 2007, 246(2):295-300.
  • 6Tabernero J, Van Cutsem E, Diaz-Rubio E, et al. Phase 11 tri- al of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colnrectal cancer[Jl. J Clin Oncol,2007,25(33) : 5225-5232.
  • 7陆明,沈琳.结直肠癌肝转移新辅助化疗的相关问题分析[J].中国实用外科杂志,2009,29(1):26-29. 被引量:7
  • 8刘凯,李哲,段纪成,黄耀,杨家和,沈锋,吴孟超.结肠癌伴肝转移同期切除影响预后相关因素分析[J].中国实用外科杂志,2009,29(8):662-664. 被引量:4

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部